No headlines found.
ACCESSWIRE (Thu, 21-Mar 7:59 AM ET)
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
ACCESSWIRE (Thu, 29-Feb 4:28 PM ET)
abrdn U.S. Closed End Funds Announce Distribution Payment Details
ACCESSWIRE (Wed, 10-Jan 4:18 PM ET)
The Fund's investment objective is to seek current income and long-term capital appreciation through investment in companies in the healthcare industry (including equity securities, debt securities and pooled investment vehicles). This is a broad mandate and the Fund invests primarily in securities of public and private companies believed by the Fund's Investment Adviser, Tekla Capital Management LLC (the Adviser) to have significant potential for above-average growth.
Tekla Health Care Opportunities trades on the NYSE stock market under the symbol THQ.
As of March 28, 2024, THQ stock price climbed to $20.10 with 165,432 million shares trading.
THQ has a beta of 0.95, meaning it tends to be less sensitive to market movements. THQ has a correlation of 0.46 to the broad based SPY ETF.
THQ has a market cap of $831.26 million. This is considered a Small Cap stock.
In the last 3 years, THQ stock traded as high as $25.92 and as low as $15.29.
THQ stock has underperformed the market in the last year with a return of +17.9%, while SPY returned +33.6%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in THQ shares. However, THQ has outperformed the market in the last 3 month and 2 week periods, returning +14.0% and +1.8%, while SPY returned +10.1% and +1.7%, respectively. This indicates THQ has been having a stronger performance recently.
THQ support price is $19.83 and resistance is $20.25 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that THQ stock will trade within this expected range on the day.